论文部分内容阅读
目的:探讨中晚期恶性肿瘤使用康艾注射液配合化疗治疗的临床现象和效果。方法:选取中晚期恶性肿瘤患者50例,随机分为A组和B组,A组患者在化疗基础上加康艾治疗,B组单纯进行化疗,将两组的治疗效果进行对比。结果:A组的好转率为48%,B组的好转率仅为16%;A组完成率明显高于B组;化疗毒副反应A组明显低于B组。结论:康艾注射液配合化疗治疗晚期恶性肿瘤,效果明显好于单纯化疗治疗,且可以提高患者对于化疗的耐受性。
Objective: To investigate the clinical effect and effect of Kangai injection combined with chemotherapy in advanced malignant tumors. Methods: Fifty patients with advanced malignant tumor were randomly divided into group A and group B. Patients in group A were treated with Kangaiyi on the basis of chemotherapy. Group B was treated with chemotherapy alone. The therapeutic effects of the two groups were compared. Results: The improvement rate of group A was 48% and that of group B was only 16%. The completion rate of group A was significantly higher than that of group B. The toxicity of chemotherapy group A was significantly lower than that of group B. Conclusion: Kangai injection with chemotherapy for advanced malignant tumors, the effect was significantly better than chemotherapy alone, and can improve the patient’s tolerance to chemotherapy.